See All Slides - tctmd.com

Slides

Presentation TCT 2013

Case #10: We Will Start Using Dedicated Bifurcation Devices!

Presenter: Niels Holm

October 30, 2013

Presentation TCT 2013

The Emergence of New-STEMI Devices: Creative Clinical Trial Pathways

Presenter: Ori Ben-Yehuda

October 30, 2013

Presentation TCT 2013

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Presenter: Charles Davidson

October 30, 2013

Presentation TCT 2013

Pre-Hospital and Emergency Department Issues and Initiatives

Presenter: Ivan Rokos

October 30, 2013

Presentation TCT 2013

The High Risk and REALISM Registries

Presenter: Scott Lim

October 30, 2013

Presentation

Bringing It All Together for Device Development/Education and Technique Optimization

Presenter: Liz Perpetua

October 31, 2013

Presentation TCT 2013

Translational Perspectives: Catheter-Based Mitral Intervention Therapies: Experimental Validation Pathways and Challenges

Presenter: Greg Kaluza

October 30, 2013

Presentation TCT 2013

Renal Intervention: Indications and Patient Selection 2013

Presenter: Christopher White

October 30, 2013

Presentation TCT 2013

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

Presenter: Deepak Bhatt

October 30, 2013

Advertisement

Slides

Case #10: We Will Start Using Dedicated Bifurcation Devices!

The Emergence of New-STEMI Devices: Creative Clinical Trial Pathways

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Pre-Hospital and Emergency Department Issues and Initiatives

The High Risk and REALISM Registries

Bringing It All Together for Device Development/Education and Technique Optimization

Translational Perspectives: Catheter-Based Mitral Intervention Therapies: Experimental Validation Pathways and Challenges

Renal Intervention: Indications and Patient Selection 2013

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content